SignatureFD’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
AAP
YIH
MCM
PI
SOADOR
LSERS
MFG
PFSRSONJ
SignatureFD's ADMA Position: Q2 2026 in Review
SignatureFD increased its ADMA Biologics (ADMA) stake by 3.3% in Q2 2026, buying an estimated $1.06K and bringing the position to 3,592 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2147.
SignatureFD first reported a position in ADMA in Q3 2022 and has held it in 16 quarters since. The position peaked at $93.6K in Q3 2024. 62 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.
- SignatureFD held 3,592 shares of ADMA Biologics worth $30.1K as of Q2 2026.
- SignatureFD bought 116 ADMA Biologics shares in Q2 2026, an estimated $1.06K.
- ADMA Biologics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2147 holding.
- SignatureFD first reported a position in ADMA Biologics in Q3 2022 and has held it in 16 quarters since.
- SignatureFD's ADMA Biologics position peaked at $93.6K in Q3 2024.
- 62 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.
Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.